ADVERTISEMENT

Lupin - Inspection Report For Goa Facility From U.S. FDA Provides Significant Respite: ICICI Direct

Lupin - Inspection Report For Goa Facility From U.S. FDA Provides Significant Respite: ICICI Direct

<div class="paragraphs"><p>Employees walk along a path at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)</p></div>
Employees walk along a path at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More